dpp-4 inhibitors vs. glp-1 agonist Role of Dipeptidyl Peptidase 4 in Antidiabetic Treatment DPP-4 inhibitors and GLP-1RAs: cardiovascular

[DOI] [PubMed] [Google Scholar] 24.Gaspari T., Welungoda I., Widdop R.E., Simpson R.W., Dear A.E

These are very effective medications as a tool to lose weight, he said

This phenomenon is also not thought to be a direct toxic effect of the drug itself, but rather a known risk associated with rapid and substantial improvement in glycemic control, which can also be observed with the initiation of intensive insulin therapy

The combination of fiber, healthy fats, and lean protein creates multiple opportunities for nutrient-stimulated hormone responses throughout the day

DPP-4 inhibitors may be a treatment option for patients in whom metformin is contraindicated due to decreased renal function or intolerable gastrointestinal side effects